HOUSTON, December 20, 2021--(BUSINESS WIRE)--Orion Group Holdings, Inc. (NYSE: ORN) (the "Company") a leading specialty construction company, today announced two contract awards for its Marine segment totaling approximately $33 million.

The Company was recently awarded a $28.3 million design-bid-build contract by the Naval Facilities Engineering Command ("NAVFAC") Southeast for the repair and update of an existing waterside facility in the Bahamas. Work on the project site is scheduled to commence in the second quarter of 2022 and to be completed in early 2024.

The Company has also been awarded a contract valued at $4.4 million to rehabilitate an existing barge dock for a private sector energy client along the gulf coast of Texas. Work is expected to begin during the first quarter of 2022 and be completed during the third quarter of 2022.

"The award from NAVFAC continues our long history of supporting the U.S. Navy’s infrastructure needs," said Mark Stauffer, Orion’s President and Chief Executive Officer. "Additionally, we are pleased to continue to be the market leader supporting the needs of our energy sector clients along the Texas gulf coast."

Orion Group Holdings, Inc., a leading specialty construction company serving the infrastructure, industrial and building sectors, provides services both on and off the water in the continental United States, Alaska, Canada and the Caribbean Basin through its marine segment and its concrete segment. The Company’s marine segment provides construction and dredging services relating to marine transportation facility construction, marine pipeline construction, marine environmental structures, dredging of waterways, channels and ports, environmental dredging, design, and specialty services. Its concrete segment provides turnkey concrete construction services including pour and finish, dirt work, layout, forming, rebar, and mesh across the light commercial, structural and other associated business areas. The Company is headquartered in Houston, Texas with regional offices throughout its operating areas.

The matters discussed in this press release may constitute or include projections or other forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, the provisions of which the Company is availing itself. Certain forward-looking statements can be identified by the use of forward-looking terminology, such as 'believes', 'expects', 'may', 'will', 'could', 'should', 'seeks', 'approximately', 'intends', 'plans', 'estimates', or 'anticipates', or the negative thereof or other comparable terminology, or by discussions of strategy, plans, objectives, intentions, estimates, forecasts, outlook, assumptions, or goals. In particular, statements regarding future operations or results, including those set forth in this press release and any other statement, express or implied, concerning future operating results or the future generation of or ability to generate revenues, income, net income, profit, EBITDA, EBITDA margin, or cash flow, including to service debt, and including any estimates, forecasts or assumptions regarding future revenues or revenue growth, are forward-looking statements. Forward looking statements also include estimated project start date, anticipated revenues, and contract options which may or may not be awarded in the future. Forward looking statements involve risks, including those associated with the Company's fixed price contracts that impacts profits, unforeseen productivity delays that may alter the final profitability of the contract, cancellation of the contract by the customer for unforeseen reasons, delays or decreases in funding by the customer, levels and predictability of government funding or other governmental budgetary constraints and any potential contract options which may or may not be awarded in the future, and are the sole discretion of award by the customer. Past performance is not necessarily an indicator of future results. In light of these and other uncertainties, the inclusion of forward-looking statements in this press release should not be regarded as a representation by the Company that the Company's plans, estimates, forecasts, goals, intentions, or objectives will be achieved or realized. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company assumes no obligation to update information contained in this press release whether as a result of new developments or otherwise.

Please refer to the Company’s Annual Report on Form 10-K, filed on March 2, 2021, which is available on its website at www.oriongroupholdingsinc.com or at the SEC’s website at www.sec.gov, for additional and more detailed discussion of risk factors that could cause actual results to differ materially from our current expectations, estimates or forecasts.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211220005188/en/

Orion Group Holdings Inc. Francis Okoniewski, Vice President Investor Relations (346) 616-4138 fokoniewski@orn.net www.oriongroupholdingsinc.com

Dow Jones futures tilted higher Sunday night, along with S&P 500 futures and Nasdaq futures. The stock market rally revived last week, with the S&P 500 nearly at a new high while a diverse list of leaders flashed buy signals, including AMD stock and Google parent Alphabet.

When looking for investment ideas for 2022, it pays to look at those stocks that have beaten the market in 2021. Savvy investors know that winners tend to keep on winning, so picking stocks that are already in the market-beating category can increase your odds of investing success.

Naren Gupta, a venture capitalist who co-founded Nexus Venture Partners to help plant Indian SaaS startups on the world map, died on Saturday. Gupta, who moved to the U.S. to pursue higher education in late 1960s, co-founded Integrated Systems, a software firm that was ultimately sold to Intel. After leaving the firm, he began to explore investment opportunities.

Skyworks Solutions (NASDAQ: SWKS) and Chewy (NYSE: CHWY) haven't been the best performers in 2021, as shares of both companies have dipped despite terrific growth in their businesses. Let's look at the reasons why Skyworks Solutions and Chewy could go on a bull run and leave this year's disappointing performance behind. Skyworks Solutions stock has dipped of late thanks to speculation that the demand for Apple's (NASDAQ: AAPL) iPhone would take a hit in the holiday season.

Buying a stock is easy, but buying the right stock without a time-tested strategy is incredibly hard. So what are the best stocks to buy now or put on a watchlist?

(Bloomberg) -- Asian stocks were mixed and U.S. equity futures were steady Monday amid a mood of caution as traders evaluated spiking coronavirus cases and a weekend pledge of greater economic support from China’s central bank.Most Read from BloombergCoronavirus Can Persist for Months After Traversing BodyCases Surge Globally; Fauci Warns of Complacency: Virus UpdateChina Reports Most Daily Local Infection Cases Since JanuaryWorld Economy Now Set to Surpass $100 Trillion in 2022Alex Jones' Wife

The dividends for such stocks are pretty much their only attraction. On the other hand, you can find dividend stocks that are anything but boring and stodgy. Here are three dividend stocks that soared more than 50% in 2021 and are still great buys.

SAND and MANA are two of the leading projects in the metaverse space at the moment, and their positive momentum could extend into the coming year.

Abbott Laboratories (NYSE: ABT) shares have gained around 26% in 2021. Despite the big payout bumps, Abbott only needed around 33% of the free cash flow its operations generated over the past year to make dividend payments. Despite pandemic pressure, medical-device segment sales during the first nine months of 2021 rose 24.5% year over year to $10.6 billion.

We’re about to turn the page on the calendar, put 2021 behind us, and stride into the brave, new year of 2022 – and Wall Street’s prognosticators are busy scanning the stocks to find the winners and losers for next year’s markets. Whether it’s individual stocks, whole industry sectors, or some combination of both, the analysts are finding plenty of Buy-rated equities for investors to consider. Take the automotive sector. Few industrials will present as many investment opportunities, both in 2022

Wall Street's consensus price target for Teladoc Health (NYSE: TDOC) stock over the next 12 months reflects a 67% upside potential. It's quite possible that the spread of the omicron variant of COVID-19 could give Teladoc a boost in the near term. Teladoc enjoyed a big surge in virtual visits in 2020 thanks to the pandemic.

Hundreds of Chinese companies are listed on U.S. markets. But which are the best Chinese stocks to buy or watch right now? JD.com , Nio, Li Auto, Xpeng and BYD Co.. China is the world's most-populous nation and the second-largest economy with a booming urban middle class and amazing entrepreneurial activity.

Will SPY continue the bull run in 2022 after the FED announced it will accelerate the reduction of its monthly bond purchases?

Boeing recorded 109 737 Max orders in November and some 767 freighter orders in December. Is Boeing stock a good buy now?

MP Materials director Randall Weisenburger bought $3.5 million of shares. MP has a deal to provide General Motors with rare-earth magnets.

(Bloomberg) -- A world-beating share rally by a Thai technology company after it unveiled an expansion into Bitcoin mining has surprised even the firm’s chairman. Most Read from BloombergCoronavirus Can Persist for Months After Traversing BodyCases Surge Globally; Fauci Warns of Complacency: Virus UpdateChina Reports Most Daily Local Infection Cases Since JanuaryWorld Economy Now Set to Surpass $100 Trillion in 2022Alex Jones' Wife Arrested on Domestic Violence ChargeJasmine Technology Solution

There's no denying that 2021 has been a rough year for many biotech stocks. The shares of quite a few big and small biotech companies alike are set to finish the year in negative territory. Here's why they chose Axsome Therapeutics (NASDAQ: AXSM), Novartis (NYSE: NVS), and Vertex Pharmaceuticals (NASDAQ: VRTX).

(Bloomberg) -- The head of Norway’s $1.4 trillion wealth fund said he expects a lengthy period of weakness in financial markets and warned that inflation could be the most significant challenge ahead.Most Read from BloombergCoronavirus Can Persist for Months After Traversing BodyCases Surge Globally; Fauci Warns of Complacency: Virus UpdateChina Reports Most Daily Local Infection Cases Since JanuaryWorld Economy Now Set to Surpass $100 Trillion in 2022Alex Jones' Wife Arrested on Domestic Violen

2021 was a mixed bag for the renewable energy industry, but investors should stay focused on the companies in this space that have what it takes to be winners over the long haul.

Investors often have to choose between an attractive growth stock and dividend stock. This time, they get both.